Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Quantum Biopharma Ltd (QNTM)

23 + Investors. Track Smart Money conviction in QNTM. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +1
Streak
2Q ▲
Buyers last Q
68%

Smart Money Signals — QNTM

Based on 23 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added QNTM than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
23 hedge funds hold QNTM right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +77% more funds vs a year ago

fund count last 6Q
+10 new funds entered over the past year (+77% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 68% buying

13 buying6 selling
Last quarter: 13 funds were net buyers (7 opened a brand new position + 6 added to an existing one). Only 6 were sellers (0 trimmed + 6 sold completely). A clear majority buying is a strong confirmation signal.
➡️

Steady new buyers — ~7 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 7 → 4 → 8 → 7. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔄

Mostly new holders — 48% entered in last year

0% conviction (2yr+) 52% medium 48% new
Only 0 funds (0%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💎

Buying through price weakness — shares +89%, value +19%

Value
+18%
Shares
+89%
Last quarter: funds added +89% more shares while total portfolio value only changed +19%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
➡️

Steady discovery — ~7 new funds/quarter

7 → 7 → 4 → 8 → 7 new funds/Q
New funds entering each quarter: 7 → 4 → 8 → 7. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🌱

Early stage — 65% of holders entered in last year

0% veterans 35% 1-2yr 65% new
Of 23 current holders: 15 (65%) entered in the past year, only 0 (0%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

Strong quality — 24% AUM from major funds

24% from top-100 AUM funds
5 of 23 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
5.1
out of 10
Moderate Exit Risk
Exit risk score 5.1/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — QNTM

In 2026 Q1, 13 hedge funds were net buyers of QNTM (7 opened a new position, 6 added to an existing one), while 6 reduced or exited (6 sold completely) — a 68% buyer ratio, indicating clear institutional accumulation. Net buying has persisted for two consecutive quarters, a positive momentum signal. 24% of total institutional value in QNTM is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +1 funds (more new holders than closures). Total institutional holders: 23.

Hedge Fund Ownership: QNTM

How many hedge funds hold QNTM — quarterly history vs. share price
Quarterly hedge fund ownership of QNTM vs. share price

Market Analysis: QNTM

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: QNTM

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Quantum Biopharma Ltd (QNTM) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much QNTM has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 82d ago
QNTM
-21.3%
XLV
+1.9%

QNTM outperformed XLV by -23.2% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 37d ago
QNTM
-44.2%
XLV
+3.0%

Since the filing became public, QNTM outperformed XLV by -47.2% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

0 top-rated funds 0 high-conviction
Consensus
0.0
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: QNTM
23 + Investors

Track Smart Money conviction in QNTM. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 23 22 4.55%
13F Shares 241K 127K 89.3%
Total Value $1M $929K 18.8%
New Positions 7 8 -1
Increased Positions 6 4 +2
Closed Positions 6 3 +3
Reduced Positions 0 5 -5
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: QNTM

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

23 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in QNTM. Verified SEC 13F-HR filings.

QUARTER:
Top 22 QNTM holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 AdvisorShares Investments LLC 0.10% 108,591 $524K
2 Platform Technology Partners 0.04% 41,116 $199K
3 Cetera Trust Company, N.A 0.00% 250 $1K
4 Steward Partners Investment Advisory, LLC 0.00% 4,381 $21K
5 Atlantic Union Bankshares Corp 0.00% 1,000 $5K
6 Mariner, LLC 0.00% 10,059 $49K
7 Osaic Holdings, INC. 0.00% 6,375 $31K
8 Farther Finance Advisors, LLC 0.00% 1,000 $4K
9 Jane Street Group, LLC 0.00% 31,501 $152K
10 Activest Wealth Management 0.00% 15
11 Citadel Advisors LLC 0.00% 15,863 $77K
12 SBI Securities Co., Ltd. 0.00% 75
13 Tower Research Capital LLC (TRC) 0.00% 71
14 UBS Group AG 0.00% 7,237 $35K
15 Jones Financial Companies Lllp 0.00% 700 $3K
16 Federation des caisses Desjardins du Quebec 0.00% 93
17 Group One Trading LLC 0.00% 34
18 TD Waterhouse Canada Inc. 0.00% 20
19 Rockefeller Capital Management L.P. 0.00% 30
20 Purpose Unlimited Inc. 0.00% 1
21 Wells Fargo & Company/Mn 0.00% 100
22 National Bank of Canada /Fi/ 0.00% 20
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Quantum Biopharma Ltd (QNTM)

What does the Smart Money Trend signal show for QNTM?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added QNTM than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for QNTM?

More buyers than sellers — 68% buying: Last quarter: 13 funds were net buyers (7 opened a brand new position + 6 added to an existing one). Only 6 were sellers (0 trimmed + 6 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for QNTM holders?

Strong quality — 24% AUM from major funds: 5 of 23 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held QNTM?

Mostly new holders — 48% entered in last year: Only 0 funds (0%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Quantum Biopharma Ltd (QNTM) following the 2026 Q1 hedge fund 13F filings?

As of today, QNTM has moved -44.2% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.0% for the XLV sector ETF — an outperformance of -47.2%. Since the quarter end (March 31, 2026), QNTM has gained -21.3% vs +1.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →